Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Dyadic International ( (DYAI) ) is now available.
On June 20, 2025, Dyadic International, Inc. held its 2025 Annual Meeting of Shareholders where key decisions were made regarding the election of directors, ratification of the accounting firm, and executive compensation. The board decided that future advisory votes on executive compensation will occur annually, reflecting shareholder preferences and potentially impacting the company’s governance and stakeholder relations.
The most recent analyst rating on (DYAI) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Dyadic International stock, see the DYAI Stock Forecast page.
Spark’s Take on DYAI Stock
According to Spark, TipRanks’ AI Analyst, DYAI is a Neutral.
Dyadic International’s overall score reflects significant financial challenges, notably ongoing losses and negative cash flows. While strategic partnerships and revenue growth are positive, they are offset by high leverage and operational inefficiencies. The stock’s technical indicators suggest weak momentum, and its valuation remains unattractive due to unprofitability. The earnings call provides some optimism about future growth, but near-term challenges persist.
To see Spark’s full report on DYAI stock, click here.
More about Dyadic International
Dyadic International, Inc. operates in the biotechnology industry, focusing on the development and production of enzymes and proteins for various applications, including pharmaceuticals and industrial processes.
Average Trading Volume: 36,694
Technical Sentiment Signal: Sell
Current Market Cap: $27.44M
For detailed information about DYAI stock, go to TipRanks’ Stock Analysis page.